Survival analysis of patients with hepatocellular carcinoma based on the ratio of platelet count to spleen diameter
BackgroundIn China, 80% of Hepatocellular Carcinoma (HCC) is associated with cirrhosis. Portal hypertension, the most common outcome of cirrhosis progression, has a high incidence. Platelet count/spleen diameter ratio (PSL) with a cut-off value of 909 can predict the presence of esophagogastric vari...
Saved in:
Main Authors: | Huiwen Yan, Dongdong Zhou, Xiaoli Liu, Peng Wang, Tingting Jiang, Zhiyun Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1449603/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A new prognostic model for predicting overall survival and progression-free survival in unresectable hepatocellular carcinoma treated with the FOLFOX-HAIC regimen based on patient clinical characteristics and blood biomarkers
by: Qiuyao Zeng, et al.
Published: (2025-01-01) -
Advances and challenges in platelet counting: evolving from traditional microscopy to modern flow cytometry
by: Chen Yong, et al.
Published: (2025-02-01) -
Genome-Wide Association Study Identifies Candidate Loci Associated with Platelet Count in Koreans
by: Ji Hee Oh, et al.
Published: (2014-12-01) -
Platelet count and retinopathy of prematurity, a systematic review and meta-analysis
by: Qian Zeng, et al.
Published: (2025-01-01) -
Efficacy of small-diameter core decompression with platelet-rich plasma in early osteonecrosis of the femoral head: a retrospective study
by: Haiwei Tang, et al.
Published: (2025-01-01)